Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19
Status:
Recruiting
Trial end date:
2021-11-30
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate if adding rhC1-INH to standard of care (SOC)
in patients admitted for stage II COVID-19 infection may reduce the risk of disease
progression, i.e. ALI requiring mechanical ventilation, or increase the chance of a faster
clinical improvement compared to SOC alone.